Results: 1-25 | 26-45
Results: 1-25/45

Authors: Blankenship, JC Tasissa, G O'Shea, JC Iliadis, EA Bachour, FA Cohen, DJ Lui, HK Mann, T Cohen, E Tcheng, JE
Citation: Jc. Blankenship et al., Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial, J AM COL C, 38(3), 2001, pp. 653-658

Authors: Cantor, WJ Hellkamp, AS Peterson, ED Zidar, JP Cowper, PA Sketch, MH Tcheng, JE Califf, RM Ohman, EM
Citation: Wj. Cantor et al., Achieving optimal results with standard balloon angioplasty: Can baseline and angiographic variables predict stent-like outcomes?, J AM COL C, 37(7), 2001, pp. 1883-1890

Authors: Tcheng, JE Volkert-Noethen, AA
Citation: Je. Tcheng et Aa. Volkert-noethen, Current multicentre studies with the excimer laser: Design and aims, LASER MED S, 16(2), 2001, pp. 122-129

Authors: Tcheng, JE Strony, J Lorenz, TJ O'Shea, JC
Citation: Je. Tcheng et al., ESPRIT in context: pharmacology matters!, EUR HEART J, 22(21), 2001, pp. 1965-1967

Authors: O'Shea, JC Tcheng, JE
Citation: Jc. O'Shea et Je. Tcheng, Drug-company sponsorship and the Declaration of Helsinki - Reply, LANCET, 357(9266), 2001, pp. 1448-1449

Authors: Akkerhuis, KM Deckers, JW Lincoff, AM Tcheng, JE Boersma, E Anderson, K Balog, C Califf, RM Topol, EJ Simoons, ML
Citation: Km. Akkerhuis et al., Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention, J AM MED A, 286(1), 2001, pp. 78-82

Authors: O'Shea, JC Hafley, GE Greenberg, S Hasselblad, V Lorenz, TJ Kitt, MM Strony, J Tcheng, JE
Citation: Jc. O'Shea et al., Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention - The ESPRIT trial: A randomized controlled trial, J AM MED A, 285(19), 2001, pp. 2468-2473

Authors: Tcheng, JE Kereiakes, DJ Lincoff, AM George, BS Kleiman, NS Sane, DC Cines, DB Jordan, RE Mascelli, MA Langrall, MA Damaraju, L Schantz, A Effron, MB Braden, GA
Citation: Je. Tcheng et al., Abciximab readministration - Results of the ReoPro readministration registry, CIRCULATION, 104(8), 2001, pp. 870-875

Authors: Gilchrist, IC O'Shea, JC Kosoglou, T Jennings, LK Lorenz, TJ Kitt, MM Kleiman, NS Talley, D Aguirre, F Davidson, C Runyon, J Tcheng, JE
Citation: Ic. Gilchrist et al., Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention, CIRCULATION, 104(4), 2001, pp. 406-411

Authors: Steinhubl, SR Talley, JD Braden, GA Tcheng, JE Casterella, PJ Moliterno, DJ Navetta, FI Berger, PB Popma, JJ Dangas, G Gallo, R Sane, DC Saucedo, JF Jia, G Lincoff, AM Theroux, P Holmes, DR Teirstein, PS Kereiakes, DJ
Citation: Sr. Steinhubl et al., Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention - Results of the GOLD (AU-Assessing Ultegra) multicenter study, CIRCULATION, 103(21), 2001, pp. 2572-2578

Authors: Blankenship, JC Sigmon, KN Pieper, KS O'Shea, C Tardiff, BE Tcheng, JE
Citation: Jc. Blankenship et al., Effect of eptifibatide on angiographic complications during percutaneous coronary intervention in the IMPACT-(Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis) II trial, AM J CARD, 88(9), 2001, pp. 969-973

Authors: Tcheng, JE Talley, JD O'Shea, JC Gilchrist, IC Kleiman, NS Grines, CL Davidson, CJ Lincoff, AM Califf, RM Jennings, LK Kitt, MM Lorenz, TJ
Citation: Je. Tcheng et al., Clinical pharmacology of higher dose eptifibatide in percutaneous coronaryintervention (the PRIDE study), AM J CARD, 88(10), 2001, pp. 1097-1102

Authors: Gibson, CM Cohen, DJ Cohen, EA Lui, HK Murphy, SA Marble, SJ Kitt, M Lorenz, T Tcheng, JE
Citation: Cm. Gibson et al., Effect of Eptifibatide on coronary flow reserve following coronary stent implantation - (An ESPRIT substudy), AM J CARD, 87(11), 2001, pp. 1293-1295

Authors: Madan, M Berkowitz, SD Christie, DJ Jennings, LK Smit, AC Sigmon, KN Glazer, S Tcheng, JE
Citation: M. Madan et al., Rapid assessment of glycoprotein IIb/IIIa blockade with the platelet function analyzer PFA-100 during percutaneous coronary intervention, AM HEART J, 141(2), 2001, pp. 226-233

Authors: Tanguay, JF Cantor, WJ Krucoff, MW Muhlestein, B Barsness, GW Zidar, JP Sketch, MH Tcheng, JE Phillips, HR Stack, RS Kaplan, AV Ohman, EM
Citation: Jf. Tanguay et al., Local delivery of heparin post-PTCA: A multicenter randomized pilot study, CATHET C IN, 49(4), 2000, pp. 461-467

Authors: Kandzari, DE Tcheng, JE Harrington, RA Sketch, MH
Citation: De. Kandzari et al., "Rescue"' platelet GP IIb/IIIa inhibitor therapy in percutaneous coronary intervention: Bailing out of a sunken ship, J INVAS CAR, 12(10), 2000, pp. 502-504

Authors: O'Shea, JC Tcheng, JE
Citation: Jc. O'Shea et Je. Tcheng, Small-molecule glycoprotein IIb/IIIa inhibitors as adjunctive therapy in percutaneous coronary interventions, J THROMB TH, 10(3), 2000, pp. 211-215

Authors: Cantor, WJ Peterson, ED Popma, JJ Zidar, JP Sketch, MH Tcheng, JE Ohman, EM
Citation: Wj. Cantor et al., Provisional stenting strategies: Systematic overview and implications for clinical decision-making, J AM COL C, 36(4), 2000, pp. 1142-1151

Authors: Cho, L Topol, EJ Balog, C Foody, JM Booth, JE Cabot, C Kleiman, NS Tcheng, JE Califf, R Lincoff, MA
Citation: L. Cho et al., Clinical benefit of glycoprotein IIb/IIIa blockade with abciximab is independent of gender - Pooled analysis from EPIC, EPILOG and EPISTENT trials, J AM COL C, 36(2), 2000, pp. 381-386

Authors: Tcheng, JE
Citation: Je. Tcheng, High-dose eptifibatide in elective coronary stenting: Results of the ESPRIT trial, J AM COL C, 36(1), 2000, pp. 321-321

Authors: Tcheng, JE O'Shea, JC Cohen, EA Pacchiana, CM Kitt, MM Lorenz, TJ Greenberg, S Strony, J Califf, RM Buller, C Cantor, WJ Joseph, DM Kitt, MM Lincoff, AM Madan, M Popma, J Teirstein, P Cohen, E Balleza, L Parsons, P Lui, H Young, J Fox, R Labinaz, M Jelley, J Williams, J Cohen, D Trovato, M Smith, J Henry, P Chisholm, R O'Donnell, D Talley, JD Pacheco, R Timmis, S Muraka, A Mann, T Cubeddu, G Tannenbaum, M Greene, J Santoian, E Wash, M Sheldon, S Pronesti, L Jain, A Alonzo, M Seidelin, P Richards, J Lopez, M Dittenber, R Johnson, K Levine, G Maresh, K Ferrando, T Sarembock, I Snyder, L Kieval, J Herlan, L Miller, M Bembridge, D Nair, R Hickel, L Kiernan, F Murphy, D Cloutier, J Conn, E Beardsley, J Ritchie, M Cragen, D Jafar, MZ Counihan, P Rosenfelder, D Ducas, J Montebruno, L Carere, R Radons, B Williams, L Owens, W Dougal, R Feldman, R Audrain, D Karamali, A Smith, M Blankenship, J Demko, SL Thompson, M Gacoich, G Chiodo, V Noll, P Ledley, G Miller, C Felten, W Garner, B Chandler, AB Easler, P Albin, G Page, A Maddox, W Allen, S Gilchrist, I Moore, R Zimmerman, H Curtis, M Hildebrand, K Greene, R Healy, E Meengs, W Carson, D George, J Roncevich, T Aharonian, V Browning, R Kostuk, W Carr, S Feit, F Gostomsky, B Butman, S Hannah, E Hassel, CD Hartley, D Shook, T Hiller-Mullin, S Brill, D Dillion, M Armstrong, B Kerns, D Pichard, A Okubagzi, P Nasser, T Driver, L Garrett, J Boltey, L Stouffer, G Potter, M Amidon, T Eggert, S Taussig, A Potter, K Natarajan, M Tartaglia, C Werner, J Dunlap, T Harrold-Runge, P Davidson, C Goodreau, L Herzog, W Calamunci, N Slater, A Tormey, D Phillips, W White, D Sridhar, K White, J Goodman, D Buchbinder, M Nasser, V Rapeport, K Vorman, P Weiner, B Borbone, M Shadoff, N Paap, C Rehman, A Haag, E Burchenal, J Kioussopoulos, K Senior, D Senior, J Piana, R Kirshenbaum, J Chan, S Chowdry, A Kraft, P Clark, V Fox, M Deutsch, E Shannon, T Quesada, R Brotherton, J Murrin, C Cinderella, J Hearne, S Seefried, V Farah, T Pakstis, D Bartolet, B Bond, C Debarardinis, C Montory, D Smith, G Gray, D Phillips, P Hathaway, S Manoukian, S Patrick, C Yakubov, S Brooks, J Block, P Block, B Muhlestein, JB Kim, S Shalev, Y Schmidt, W Resar, J Citro, K Stine, R Zumbuhl, J Moreyra, A Kreiger, S Berger, P Cannon, CP Fisher, L Hasselblad, V Foster, A Joseph, D Madan, M McLendon, C Rund, M Tillery, N Wood, F Mahaffey, KW Irwin, C Kulick, D Johnson, N Chen, J Greenberg, S Hogeboom, C Lorenz, TJ Terifay, R Strony, J Veltri, E
Citation: Je. Tcheng et al., Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial, LANCET, 356(9247), 2000, pp. 2037-2044

Authors: Lincoff, AM Mark, DB Tcheng, JE Califf, RM Bala, MV Anderson, KM Davidson-Ray, L Knight, JD Cabot, CF Topol, EJ
Citation: Am. Lincoff et al., Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization - Results from the EPILOG randomized trial, CIRCULATION, 102(24), 2000, pp. 2923-2929

Authors: Lincoff, AM LeNarz, LA Despotis, GJ Smith, PK Booth, JE Raymond, RE Sapp, SK Cabot, CF Tcheng, JE Califf, RM Effron, MB Topol, EJ
Citation: Am. Lincoff et al., Abciximab and bleeding during coronary surgery: Results from the EPILOG and EPISTENT trials, ANN THORAC, 70(2), 2000, pp. 516-526

Authors: Bhatt, DL Lincoff, M Califf, RM Simoons, ML Tcheng, JE Brener, SJ Wolski, KE Topol, EJ
Citation: Dl. Bhatt et al., The benefit of abciximab in percutaneous coronary revascularization is notdevice-specific, AM J CARD, 85(9), 2000, pp. 1060-1064

Authors: Thel, MC Califf, RM Tardiff, BE Gardner, LH Sigmon, KN Lincoff, AM Topol, EJ Kitt, MM Blankenship, JC Tcheng, JE
Citation: Mc. Thel et al., Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II), AM J CARD, 85(4), 2000, pp. 427-434
Risultati: 1-25 | 26-45